The CRO industry has a choice to make: their leaders can retire to a plantation, as the famous pirate Henry Morgan did, or they can adapt their model to one that is technology driven and cost-efficient, leveraging it to deliver clinical trials, says Taimei’s Scott Clark.

The pharmaceutical industry is fuelled by data. Huge amounts of information are available from sources as diverse as patient health records, wearables, and social media content. If sponsors can harness it, this data can provide the key to saving time, labour and costs across the pharmaceutical value chain, ultimately bringing better drug products to patients sooner.

Traditional approaches to payment management for clinical trials are highly manual, labour-intensive, and subject to human error. In an industry where timelines are critical and accuracy is paramount, sponsors seek a better way to negotiate, track and reconcile trial payments. Automation takes away the manual burden while offering new levels of speed and accuracy.

AI spending in the pharma space is set to grow. Advanced technologies offer opportunities to increase efficiency, quality, and speed at every stage of clinical research.

Taimei Technology and IHiS will co-develop Ethics and Compliance Online System (ECOS) to serve TWO (2) healthcare clusters in Singapore. Singapore Health Services (SingHealth) and

CSI Medical Research, a Singapore Headquartered Clinical Research Organisation (CRO) company has chosen Taimei Technology’s innovative clinical research solutions as its eClinical platform. CSI Medical